TY  - JOUR
AU  - Cantudo-Cuenca, M D
AU  - Gutiérrez-Pizarraya, Antonio
AU  - Pinilla-Fernández, Ana
AU  - Contreras-Macías, Enrique
AU  - Fernández-Fuertes, M
AU  - Lao-Domínguez, F A
AU  - Rincón, Pilar
AU  - Pineda, Juan Antonio
AU  - Macías, Juan
AU  - Morillo-Verdugo, Ramón
PY  - 2021
DO  - 10.1038/s41598-021-91953-2
UR  - https://hdl.handle.net/10668/27699
T2  - Scientific reports
AB  - Primary aim was to assess prevalence and severity of potential and real drug-drug interactions (DDIs) among therapies for COVID-19 and concomitant medications in hospitalized patients with confirmed SARS-CoV-2 infection. The secondary aim was to...
LA  - en
KW  - Aged
KW  - Analgesics
KW  - COVID-19
KW  - Cardiovascular Diseases
KW  - Cohort Studies
KW  - Diuretics
KW  - Drug Interactions
KW  - Female
KW  - Humans
KW  - Hydroxychloroquine
KW  - Lopinavir
KW  - Male
KW  - Middle Aged
KW  - Nervous System Diseases
KW  - Polypharmacy
KW  - Risk Factors
KW  - Ritonavir
KW  - SARS-CoV-2
KW  - Severity of Illness Index
KW  - Spain
KW  - COVID-19 Drug Treatment
TI  - Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain.
TY  - research article
VL  - 11
ER  -